Pharmaforce Infosoft Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 116.79%
- Profit Growth 103.46%
- Ebitda 118.98%
- Net Worth 136.38%
- Total Assets 162.24%
About Pharmaforce Infosoft
Pharmaforce Infosoft Private Limited (PIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 03 September 2020 (Four years and four months 30 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mukesh Yadav and Daniel Dimitri serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72900TG2020FTC143455
-
Company No.
143455
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
03 Sep 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharmaforce Infosoft?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Yadav
|
Director | 06-Feb-2024 | Current |
Daniel Dimitri
|
Director | 09-May-2024 | Current |
Financial Performance of Pharmaforce Infosoft.
Pharmaforce Infosoft Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 116.79% increase. The company also saw a substantial improvement in profitability, with a 103.46% increase in profit. The company's net worth Soared by an impressive increase of 136.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaforce Infosoft?
In 2022, Pharmaforce Infosoft had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Matrixmind Innovations Private LimitedMukesh Yadav and Daniel Dimitri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmaforce Infosoft?
Pharmaforce Infosoft has a workforce of 103 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaforce Infosoft, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaforce Infosoft's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
